S
Steven L. Galetta
Researcher at New York University
Publications - 142
Citations - 11301
Steven L. Galetta is an academic researcher from New York University. The author has contributed to research in topics: Concussion & Optic neuritis. The author has an hindex of 37, co-authored 142 publications receiving 8303 citations. Previous affiliations of Steven L. Galetta include University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson,Brenda Banwell,Frederik Barkhof,Frederik Barkhof,William M. Carroll,Timothy Coetzee,Giancarlo Comi,Jorge Correale,Franz Fazekas,Massimo Filippi,Mark S. Freedman,Kazuo Fujihara,Steven L. Galetta,Hans-Peter Hartung,Ludwig Kappos,Fred D. Lublin,Ruth Ann Marrie,Aaron E. Miller,David Miller,Xavier Montalban,Xavier Montalban,Ellen M. Mowry,Per Soelberg Sørensen,Mar Tintoré,Anthony Traboulsee,Maria Trojano,Bernard M. J. Uitdehaag,Sandra Vukusic,Sandra Vukusic,Emmanuelle Waubant,Brian G. Weinshenker,Stephen C. Reingold,Jeffrey A. Cohen +32 more
TL;DR: The 2017 McDonald criteria continue to apply primarily to patients experiencing a typical clinically isolated syndrome, define what is needed to fulfil dissemination in time and space of lesions in the CNS, and stress the need for no better explanation for the presentation.
Journal ArticleDOI
Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis
Richard A. Rudick,WH Stuart,Peter A. Calabresi,Christian Confavreux,Steven L. Galetta,Ernst Wilhelm Radue,Fred D. Lublin,Bianca Weinstock-Guttman,Daniel Wynn,F Lynn,Michael Panzara,Alfred Sandrock +11 more
TL;DR: Natalizumab added to interferon beta-1a was significantly more effective in patients with relapsing multiple sclerosis, and additional research is needed to elucidate the benefits and risks of this combination treatment.
Journal ArticleDOI
Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
Jennifer B. Fisher,Dina A. Jacobs,Clyde E. Markowitz,Steven L. Galetta,Nicholas J. Volpe,M. Ligia Nano-Schiavi,Monika Baier,Elliot M. Frohman,Heather Winslow,Teresa C. Frohman,Peter A. Calabresi,Maureen G. Maguire,Gary Cutter,Laura J. Balcer +13 more
TL;DR: Scores for low-contrast letter acuity and contrast sensitivity correlate well with RNFL thickness as a structural biomarker, supporting validity for these visual function tests as secondary clinical outcome measures for MS trials.
Journal ArticleDOI
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.
Lauren S. Talman,Esther R. Bisker,David J. Sackel,David A. Long,Kristin M. Galetta,John N. Ratchford,Deacon J. Lile,Sheena K. Farrell,Michael J. Loguidice,Gina Remington,Amy Conger,Teresa C. Frohman,Dina A. Jacobs,Clyde E. Markowitz,Gary Cutter,Gui-Shuang Ying,Yang Dai,Maureen G. Maguire,Steven L. Galetta,Elliot M. Frohman,Peter A. Calabresi,Laura J. Balcer +21 more
TL;DR: Cross‐sectional studies of optical coherence tomography show that retinal nerve fiber layer thickness is reduced in multiple sclerosis (MS) and correlates with visual function, and how longitudinal changes in RNFL thickness relate to visual loss is determined.
Journal ArticleDOI
Ganglion cell loss in relation to visual disability in multiple sclerosis.
Scott D. Walter,Hiroshi Ishikawa,Kristin M. Galetta,Reiko E. Sakai,Daniel J. Feller,Sam B. Henderson,James A. Wilson,Maureen G. Maguire,Steven L. Galetta,Elliot M. Frohman,Peter A. Calabresi,Joel S. Schuman,Laura J. Balcer +12 more
TL;DR: It is demonstrated that GCL+IPL thinning is most significantly correlated with both visual function and vision-specific QOL in MS, and may serve as a useful structural marker of disease.